These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37161078)

  • 1. Dose-response relationships of LSD-induced subjective experiences in humans.
    Hirschfeld T; Prugger J; Majić T; Schmidt TT
    Neuropsychopharmacology; 2023 Oct; 48(11):1602-1611. PubMed ID: 37161078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model.
    Wießner I; Falchi M; Palhano-Fontes F; Feilding A; Ribeiro S; Tófoli LF
    Psychol Med; 2023 Mar; 53(4):1151-1165. PubMed ID: 34253268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of consciousness and mystical-type experiences after acute LSD in humans.
    Liechti ME; Dolder PC; Schmid Y
    Psychopharmacology (Berl); 2017 May; 234(9-10):1499-1510. PubMed ID: 27714429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting subjective effects of LSD in normal subjects.
    Schmid Y; Liechti ME
    Psychopharmacology (Berl); 2018 Feb; 235(2):535-545. PubMed ID: 28918441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.
    Stocker K; Hartmann M; Ley L; Becker AM; Holze F; Liechti ME
    J Psychopharmacol; 2024 Jan; 38(1):80-100. PubMed ID: 37905369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenomenology, Structure, and Dynamic of Psychedelic States.
    Preller KH; Vollenweider FX
    Curr Top Behav Neurosci; 2018; 36():221-256. PubMed ID: 28025814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.
    Holze F; Vizeli P; Müller F; Ley L; Duerig R; Varghese N; Eckert A; Borgwardt S; Liechti ME
    Neuropsychopharmacology; 2020 Feb; 45(3):462-471. PubMed ID: 31733631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD.
    Lawn T; Dipasquale O; Vamvakas A; Tsougos I; Mehta MA; Howard MA
    Psychopharmacology (Berl); 2022 Jun; 239(6):1797-1808. PubMed ID: 35322297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.
    Ley L; Holze F; Arikci D; Becker AM; Straumann I; Klaiber A; Coviello F; Dierbach S; Thomann J; Duthaler U; Luethi D; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2023 Oct; 48(11):1659-1667. PubMed ID: 37231080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater subjective effects of a low dose of LSD in participants with depressed mood.
    Molla H; Lee R; Tare I; de Wit H
    Neuropsychopharmacology; 2024 Apr; 49(5):774-781. PubMed ID: 38042914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.
    Holze F; Vizeli P; Ley L; Müller F; Dolder P; Stocker M; Duthaler U; Varghese N; Eckert A; Borgwardt S; Liechti ME
    Neuropsychopharmacology; 2021 Feb; 46(3):537-544. PubMed ID: 33059356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural correlates of the LSD experience revealed by multimodal neuroimaging.
    Carhart-Harris RL; Muthukumaraswamy S; Roseman L; Kaelen M; Droog W; Murphy K; Tagliazucchi E; Schenberg EE; Nest T; Orban C; Leech R; Williams LT; Williams TM; Bolstridge M; Sessa B; McGonigle J; Sereno MI; Nichols D; Hellyer PJ; Hobden P; Evans J; Singh KD; Wise RG; Curran HV; Feilding A; Nutt DJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4853-8. PubMed ID: 27071089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.
    Tagliazucchi E; Roseman L; Kaelen M; Orban C; Muthukumaraswamy SD; Murphy K; Laufs H; Leech R; McGonigle J; Crossley N; Bullmore E; Williams T; Bolstridge M; Feilding A; Nutt DJ; Carhart-Harris R
    Curr Biol; 2016 Apr; 26(8):1043-50. PubMed ID: 27085214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationships of psilocybin-induced subjective experiences in humans.
    Hirschfeld T; Schmidt TT
    J Psychopharmacol; 2021 Apr; 35(4):384-397. PubMed ID: 33663259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD alters dynamic integration and segregation in the human brain.
    Luppi AI; Carhart-Harris RL; Roseman L; Pappas I; Menon DK; Stamatakis EA
    Neuroimage; 2021 Feb; 227():117653. PubMed ID: 33338615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).
    Nichols DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2331-2343. PubMed ID: 29461039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing Psychedelics and MDMA.
    Liechti ME; Holze F
    Curr Top Behav Neurosci; 2022; 56():3-21. PubMed ID: 34734392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.
    Murray CH; Tare I; Perry CM; Malina M; Lee R; de Wit H
    Psychopharmacology (Berl); 2022 Jun; 239(6):1735-1747. PubMed ID: 34613430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The paradoxical psychological effects of lysergic acid diethylamide (LSD).
    Carhart-Harris RL; Kaelen M; Bolstridge M; Williams TM; Williams LT; Underwood R; Feilding A; Nutt DJ
    Psychol Med; 2016 May; 46(7):1379-90. PubMed ID: 26847689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.